APOB and familial hypercholesterolemia: Because of the unique role of MTP in lipid metabolism, it has become an important novel drug target for lowering blood lipid levels and for treating disorders characterized by the elevated production of apoB-containing lipoproteins, including atherosclerosis, metabolic syndrome, familial hypercholesterolemia and hypertriglyceridemia [8,10,11].